A012790 logo

Sinil Pharmaceutical Co., Ltd. Stock Price

KOSDAQ:A012790 Community·₩70.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A012790 Share Price Performance

₩6,150.00
150.00 (2.50%)
₩6,150.00
150.00 (2.50%)
Price ₩6,150.00

A012790 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

1 Risk
1 Reward

Sinil Pharmaceutical Co., Ltd. Key Details

₩81.0b

Revenue

₩44.5b

Cost of Revenue

₩36.5b

Gross Profit

₩25.2b

Other Expenses

₩11.3b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
994.30
45.08%
13.97%
0%
View Full Analysis

About A012790

Founded
1971
Employees
n/a
CEO
Mi-Keun Jung
WebsiteView website
www.sinilpharm.com

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Recent A012790 News & Updates

Recent updates

No updates